Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic

Carolien M S Schophuizen1, Martijn J Wilmer, Jitske Jansen

  • 1Department of Pediatric Nephrology, Radboud University Nijmegen Medical Centre, 6525 GA, Nijmegen, The Netherlands.

Insights

Cationic uremic toxins, including polyamines and guanidino compounds, inhibit organic cation transport in kidney cells. This study demonstrates their interaction with renal transporters, potentially impacting kidney disease progression.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Organic cations accumulate in kidney failure due to impaired renal clearance.
  • Uremic toxins, such as polyamines and guanidino compounds, are implicated in kidney disease progression.

Purpose of the Study:

  • To investigate the interaction of cationic uremic toxins with renal organic cation transport.
  • To characterize the inhibitory effects of specific uremic toxins on transporter activity in human proximal tubule cells.

Main Methods:

  • Utilized a conditionally immortalized human proximal tubule epithelial cell line (ciPTEC).
  • Measured transporter activity via uptake of the fluorescent substrate ASP(+).
  • Determined inhibitory potencies (IC50) and interaction types (Dixon plot) for various cationic uremic toxins.

Main Results:

  • Confirmed functional organic cation transporter 2 (OCT2) expression in ciPTEC.
  • All tested uremic toxins, including polyamines and guanidino compounds, inhibited ASP(+) uptake.
  • Acrolein showed the most potent inhibition (IC50 = 44 ± 2 μM) with competitive or mixed interaction (Ki = 93 ± 16 μM).
  • Mixtures of toxins exhibited complex, biphasic inhibition patterns.

Conclusions:

  • ciPTEC is a suitable model for studying cationic xenobiotic interactions.
  • Inhibition of cellular uptake transport by uremic toxins suggests a role in kidney disease progression.
  • Further research is warranted to elucidate the clinical significance of these interactions.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...